XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Collaborations - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Oct. 22, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Dec. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Proceeds from issuance of common stock, net of issuance costs         $ 134,878,000    
Related party revenue recognized   $ 6,169,000 $ 3,594,000 $ 8,094,000 6,929,000    
Related party collaboration receivables             $ 110,000
Ultragenyx [Member] | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Milestone payments upon achievement of regulatory milestone       $ 65,000,000      
Percentage of option to fund of development cost       30.00%      
Percentage of net income and net losses on net sales       30.00%      
Agreement termination notice period       90 days      
Issued and sold shares of common stock 7,825,797            
Common stock issued price per share $ 5.1113            
Proceeds from issuance of common stock, net of issuance costs $ 40,000,000            
Percentage of outstanding common stock 14.45%            
Transaction price determined under ASC 606       $ 22,513,000      
Transaction price       0      
Related party revenue recognized   6,169,000 $ 3,594,000 8,094,000 $ 6,929,000    
Deferred revenue - related party   0   0   $ 6,170,000 8,080,000
Related party collaboration receivables   $ 0   0   $ 14,000 $ 110,000
Maximum [Member] | Ultragenyx [Member] | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Milestone payments upon achievement of development milestone       25,000,000      
Milestone Payments upon achievement of net sales milestones       $ 165,000,000      
Percentage of outstanding common stock       10.00%      
Minimum [Member] | Ultragenyx [Member] | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Percentage of outstanding common stock       10.00%